Kwon BS - Search Results

1

Depletion of Alloreactive T-Cells by Anti-CD137-Saporin Immunotoxin.

Lee SC, Seo KW, Kim HJ, Kang SW, Choi HJ, Kim A, Kwon BS, Cho HR, Kwon B. Lee SC, et al. Among authors: kwon b, kwon bs. Cell Transplant. 2015;24(6):1167-81. doi: 10.3727/096368914X679327. Epub 2014 Mar 3. Cell Transplant. 2015. PMID: 24594433 Free article.

2

Anti-CD137 Suppresses Tumor Growth by Blocking Reverse Signaling by CD137 Ligand.

Kang SW, Lee SC, Park SH, Kim J, Kim HH, Lee HW, Seo SK, Kwon BS, Cho HR, Kwon B. Kang SW, et al. Among authors: kwon b, kwon bs. Cancer Res. 2017 Nov 1;77(21):5989-6000. doi: 10.1158/0008-5472.CAN-17-0610. Epub 2017 Sep 18. Cancer Res. 2017. PMID: 28923858

3

4-1BB (CD137) signals depend upon CD28 signals in alloimmune responses.

Lee EA, Kim JE, Seo JH, Kwon BS, Nam SH, Kwon B, Cho HR. Lee EA, et al. Among authors: kwon b, kwon bs. Exp Mol Med. 2006 Dec 31;38(6):606-15. doi: 10.1038/emm.2006.72. Exp Mol Med. 2006. PMID: 17202836

4

Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation.

Kim HJ, Lee JS, Kim JD, Cha HJ, Kim A, Lee SK, Lee SC, Kwon BS, Mittler RS, Cho HR, Kwon B. Kim HJ, et al. Among authors: kwon b, kwon bs. Proc Natl Acad Sci U S A. 2012 Jan 3;109(1):E13-22. doi: 10.1073/pnas.1112256109. Epub 2011 Dec 12. Proc Natl Acad Sci U S A. 2012. PMID: 22160719 Free PMC article.

5

4-1BB signaling breaks the tolerance of maternal CD8+ T cells that are reactive with alloantigens.

Kim KH, Choi BK, Kim JD, Kim YH, Lee SK, Suh JH, Lee SC, Kang SW, Kwon BS. Kim KH, et al. Among authors: kwon bs. PLoS One. 2012;7(9):e45481. doi: 10.1371/journal.pone.0045481. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23029041 Free PMC article.

6

Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells.

Kim J, Choi WS, La S, Suh JH, Kim BS, Cho HR, Kwon BS, Kwon B. Kim J, et al. Among authors: kwon b, kwon bs. Blood. 2005 Mar 1;105(5):2206-13. doi: 10.1182/blood-2004-06-2080. Epub 2004 Nov 2. Blood. 2005. PMID: 15522958 Free article.

7

Immunity to melanoma mediated by 4-1BB is associated with enhanced activity of tumour-infiltrating lymphocytes.

Ju SA, Lee SC, Kwon TH, Heo SK, Park SM, Paek HN, Suh JH, Cho HR, Kwon B, Kwon BS, Kim BS. Ju SA, et al. Among authors: kwon th, kwon b, kwon bs. Immunol Cell Biol. 2005 Aug;83(4):344-51. doi: 10.1111/j.1440-1711.2005.01330.x. Immunol Cell Biol. 2005. PMID: 16033529

8

Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.

Cho HR, Kwon B, Yagita H, La S, Lee EA, Kim JE, Akiba H, Kim J, Suh JH, Vinay DS, Ju SA, Kim BS, Mittler RS, Okumura K, Kwon BS. Cho HR, et al. Among authors: kwon b, kwon bs. Transpl Int. 2004 Aug;17(7):351-61. doi: 10.1007/s00147-004-0726-3. Epub 2004 Jul 31. Transpl Int. 2004. PMID: 15349720 Free article.

9

Involvement of tumor necrosis factor receptor superfamily(TNFRSF) members in the pathogenesis of inflammatory diseases.

Kwon B, Kim BS, Cho HR, Park JE, Kwon BS. Kwon B, et al. Among authors: kwon bs. Exp Mol Med. 2003 Feb 28;35(1):8-16. doi: 10.1038/emm.2003.2. Exp Mol Med. 2003. PMID: 12642898 Review.

10

4-1BB functions as a survival factor in dendritic cells.

Choi BK, Kim YH, Kwon PM, Lee SC, Kang SW, Kim MS, Lee MJ, Kwon BS. Choi BK, et al. Among authors: kwon pm, kwon bs. J Immunol. 2009 Apr 1;182(7):4107-15. doi: 10.4049/jimmunol.0800459. J Immunol. 2009. PMID: 19299708 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

544 results

Search Page